INTRODUCTION
Helicobacter pylori (Hp) is an important etiological factor in chronic gastritis and peptic ulcer diseases 1 . Drugs of Hp eradication are available but are costly and have documented side effects 2 . Plants are not reported for their helicobacericidal activity yet. So, in this view, a plant used for treating ulcer traditionally viz., Cissus quadrangularis 3, 4 was screened for its helicobatericidal activity. Three morphovariants of this plant viz., squarestemmed, round-stemmed and flat-stemmed are available and differentiated as variant I, II and III respectively. Variant I is a common plant widely distributed in hotter parts of India widely used and studied for gastric problems 5, 6 . The round-stemmed variety (variant II) is not much studied 7 , which is also considered to be a plant for gastric ulcer. The antiulcer potential of this plant has been carried out pharmacologically 8 . Hence, microbiological screening for its helicobactericidal activity was carried out.
MATERIALS AND METHODS
C.quadrangularis L. variant II (Vitaceae) was identified according to standard methods 9 . A voucher specimen has been deposited in the department for future reference (TU 190) . C.quadrangularis variant II was collected form the herbal garden of Tamil University, Thanjavur, Tamilnadu, India. Two seasonal samples were collected i.e., flowering in the month of April (2000) and vegetative during October (2000) with a difference of six months between the periods of sample collection 9 . Plant samples were shade dried, pulverized, filtered (40 mm mesh) and stored. Aqueous extracts (hot and cold) and solvent extracts (Acetone, Chloroform and Ethanol) were prepared according to standard methods 10 .
Human isolates of H.pylori were collected from gastic antral biopsy specimens at the site of active lesions with the help of sterile (2% gluteraldehyde) endoscopic forceps. It was transported to the laboratory in Brain Heart Infusion 11 (BHI) soft agar tubes. The biopsy specimen was transferred to modified BHI agar (Calf brain infusion -200 g/l; Beef heart infusion -250 g/l; Proteose peptone -10 g/l; Dextrose -2 g/l; NaCl -5 g/l; Disadium phosphate -2.5 g/l; Agar -15 g/l; Triphenyl tetrazolium chloride -40 mg/l; Cefatoxime -10 mg/ml; Defibrinated sheep blood -50 ml; Final pH -7.4 ± 0.2) plates and incubated at 37 0 C under microaerophilic conditions for 72 -96 h. Bacterial outgrowths from the biopsy specimen were characterized on the basis of culture, microscopic characteristics, biochemical and physiological properties. H.pylori was stored in modified BHI agar slants at 4 0 C and used for this study.
Extracts were incorporated aseptically in Standard, pre-sterilized filter discs 12 at a concentration of 5µl / disc. Simultaneously, broth culture of human H.pylori isolates was seeded on air-dried sterile Muller-Hinton agar plates 12 using a sterile cotton swab. Filter discs were placed on the H.pylori inoculated plates with the help of flame sterilized forceps and pressed gently. Plates were incubated at 37 0 C under microaerophilic condition for 48-72 h and zone of inhibition was recorded 13 .
Minimal inhibitory concentration (MIC) and determined as per standard methods 11 . For comparison, sterile filter discs with known concentration of antibiotics were obtained 10 from Hi-media and used as standard antibacterial against Hp.
RESULTS
The zone of inhibition is given in table 1.
Marginal inhibitory activity was observed in cold and hot aqueous extracts. Among the samples, plant materials drawn during flowering season is found to possess slightly higher quality of inhibitory principles. On the basis of MIC and MLC of variant II is observed to be potent against H.pylori. Chloroform extract of samples collected during flowering period showed both MIC and MLC at 40µg/ml, whereas for that during vegetative period the MIC was 40µg/ml and MLC was 45µg/ml. 14 was proved which has brought about a change in PUD management 15 . In view of its inherent cost, patient compliance, side effect profiles and risk of drug resistant mutants, a search for therapeutic alternative for Hp eradication is on. In this background, medicinal plant, which is traditionally used to treat PUD was screened against Hp.
Chloroform extracts were observed to be potent against Hp with relatively low MIC and MLC. The terpenoidal fraction might posses the helicobactericidal activity. Even though this is a promising candidate for eradication of Hp, its lower occurrence is indeed an inhibitory factor for its medicinal use in PUD 4, 16 . Pharmacological studies were carried out previously on the cytoprotective activity17 which was found to increase potassium ion concentrations. This plays an important role in protecting the gastric and duodenal mucosa. This result also support our finding wherein the increase in bicarbonates helps in building up of mucosal barrier against Hp. Further characterization, structural elucidation and in-situ clinical evaluation on human volunteers will open a new view for the traditional usage, which would implement the therapeutic strategies for the eradication of the harboring bacteria of ulcerated site in the gastric tract. 
